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Abstract: BACKGROUND: many studies about the psychosocial impact of acne have been reported in international
medical literature describing quality of life as a relevant clinical outcome. It is well known that the patient's per-
ception about the disease may be different from the physician's evaluation. Therefore, it is important to use val-
idated instruments that turn the patient's subjective opinion into objective information. OBJECTIVES: to translate
into Brazilian-Portuguese language and to culturally adapt a quality of life questionnaire, the Acne-Specific
Quality of Life Questionnaire (Acne-QoL), as well as to evaluate its reliability and validity. METHODS: measure-
ment properties were assessed: 1) validity: comparison between severity and Acne-QoL domain scores, correla-
tions between acne duration and Acne-QoL domain scores, and correlation between Acne-QoL domain scores
and SF-36 components; 2) internal consistency: Cronbach's α coefficient; 3) test-retest reproducibility: intraclass
correlation coefficient and Wilcoxon test. RESULTS: Eighty subjects with a mean age of 20.5 ± 4.8 years presenting
mild (33.8%), moderate (36.2%) and severe (30%) facial acne were enrolled. Acne-QoL domain scores were simi-
lar among the different acne severity groups except for role-social domain. Subjects with shorter acne duration
presented significant higher scores. Acne-QoL domains showed significant correlations, both between them-
selves and with SF-36 role-social and mental health components. Internal consistency (0.925-0.952) and test-retest
reproducibility were considered acceptable (0.768-0.836). CONCLUSIONS: the Brazilian-Portuguese version of the
Acne-QoL is a reliable and valid satisfactory outcome measure to be used in facial acne studies.
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INTRODUCTION
Acne vulgaris is probably one of the most com-
mon skin conditions affecting the general population,
especially teenagers and young adults.1 A Brazilian
survey revealed that 59.4% of men and 54% of women
had acne, which means that this is the most prevailing
dermatosis at all age ranges from 18 to 55, with a
prevalence varying from 70.3% to 38.1%.1-4 It is estimat-
ed that, in the United States, 45 million people have
acne. Although acne vulgaris does not usually com-
promise general health, consistent studies have
demonstrated that it may cause a negative impact on
patient’s quality of life, with psychological, social well-
being, and functional abnormalities such as depres-
sion, anxiety, anger, low self-esteem, discomfort with
self-appearance, embarrassment, self-consciousness,
lowered self-concept, social withdrawal, including sui-
cidal ideation, as well as negative influence on school
and work performance. Therefore, the assessment of
the interaction between acne, emotional issues
and psyche is crucial to avoid severe damage.5-12 Recent
studies have noticed the negative impact of acne on
medical students, as well as significant associations
between suicidal ideation, mental health problems,
social impairment, and adolescents with acne.12-13
In a previous case-control study, patients with
facial acne reported a greater impact on psychological,
social and functional capacity domains of the generic
questionnaire Sickness Impact Profile (SIP), when
compared to patients without acne.14 Some authors
have observed that acne causes more impact on men-
tal health than other chronic diseases such as asthma,
epilepsy and diabetes when using the Medical
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Outcomes Study 36-Item Short Form Health Survey
(SF-36).15 However, disease-specific scales are more
accurate than the generic ones in detecting alterations
in individual health status.16,17 Several acne-specific
psychometric instruments have been developed, such
as: Acne Disability Index (ADI) (UK, 1989), Acne-
Specific Quality of Life Questionnaire  (Acne-QoL)
(USA, 1996), Assessment of the Psychological and
Social Effects of Acne  (APSEA) (UK, 1997),
Dermatology-Specific Quality of Life Instrument for
Acne (DSQL – AC) (USA, 1997) and Acne Quality of
Life (AQOL) (Canada, 1998).18-25 The Acne-QoL was
the first validated disease-specific questionnaire suit-
able for use in facial acne clinical trials to have its psy-
chometric properties (reliability, validity and respon-
siveness) soundly documented. Its development was
based on questions suggested by subjects with acne
who were evaluated during the item generation, item
reduction, and pilot testing.
In the last decades, several efforts have been
made to develop psychometric tools to be used as effi-
cacy parameters in randomized and controlled der-
matological clinical trials.26-29 Authors have been
encouraged to use health-related quality of life
(HRQoL) measuring scales recommended by the
American and European regulatory agencies.27,30
There is a paucity of Brazilian data regarding val-
idated acne-specific HRQoL instruments. Taking into
account the relevance of globalization and of the infor-
mation concerning acne-specific HRQoL studies, and
based on the rising demand for translated instruments,
the purpose of this pioneer study consists of translating
and adapting the Acne-QoL into Brazilian-Portuguese
language, creating the Brazilian-Portuguese version of
the Acne-QoL (Acne-QoL-Br) and providing further
evidence of its reliability and validity. 
MATERIAL AND METHODS
Translation and cultural adaptation
The choice for the Acne-QoL was based on the
absence, in the Brazilian literature, of acne-specific
instruments focusing on clinical and epidemiological
trials with a well-founded methodology and whose
questions have been generated by subjects’ reports.
Initially, the permission to use and translate
Acne-QoL was requested to the authors who devel-
oped the questionnaire. Furthermore, conditions con-
cerning its translation and use were fulfilled in accor-
dance with authors’ orientations and internationally
accepted standards. The committee which revised the
translations and back-translations analyzed in this
study was formed by an English teacher and five
bilingual dermatologists, one of them being the prin-
cipal investigator. The general concept was main-
tained, as well as the item level of understanding, pri-
oritizing the semantic and conceptual equivalences.
Finally, approval of the final English and Brazilian-
Portuguese versions of the Acne-QoL was obtained
from the authors.
Study design
This cross-sectional study was conducted at the
Department of Dermatology Clinic in Escola Paulista
de Medicina of the Universidade Federal de São
Paulo, Brazil. It was approved by the Institutional
Review Board of the Escola Paulista de Medicina of
the Universidade Federal de São Paulo and has there-
fore been performed in accordance with Declaration
of Helsinki (1964) and Good Clinical Practice.
Moreover, all subjects gave their informed consent
prior to their inclusion in the study, and the term of
informed and voluntary consent was considered ade-
quate and therefore accepted. All patients were
recruited as they presented or were referred for facial
acne care. The study was carried out from July 2007 to
July 2009.
Male and female subjects (13 to 35 years old)
with facial acne (classified into mild, moderate or
severe, according to the classification proposed by the
American Academy of Dermatology) from any race
were enrolled.31 The subjects answered the Acne-QoL-
Br and SF-36 questionnaires at the beginning of the
study (baseline visit). Seven days later (second visit),
they returned to retest and answered the Acne-QoL-Br
prior starting therapy. Subjects who had received acne
topical treatment in the last four weeks and/or sys-
temic treatment in the last three months prior to base-
line were excluded. The other exclusion criteria are
defined in the flowchart (Figure 1).
The Acne-QoL contains 19 questions organized
into four domains (self-perception, role-social, role-
emotional, and acne symptoms) which refer to facial
acne. For all domains, higher scores reflect better
HRQoL. The total score varies from zero to 114, distrib-
uted as follows: 0- 30 (self-perception), 0-24 (role-social),
0-30 (role-emotional), and 0-30 (acne symptoms).
Reliability
The internal consistency of the questionnaire at all
and every domain was assessed by Cronbach’s α coeffi-
cient. The presence of redundancy was also evaluated.
The test-retest reproducibility was assessed by
the intraclass correlation coefficient (ICC) for each
domain and by comparison between subjects’
answers at baseline and second visit.
Validity
The validity of the questionnaire was measured
by: i) content validity, ii) discriminative validity,
assessed by the comparison between Acne-QoL-Br
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domain scores and facial acne severity using analysis
of variance (ANOVA) and by the correlation between
Acne-QoL-Br domain scores and acne duration using
Pearson’s correlation coefficient, and iii) convergent
validity, assessed by the evaluation of the correlation
of Acne-QoL-Br domain scores with themselves and
with SF-36 domain scores using Spearman’s correla-
tion coefficient.
Statistical Analysis
The Kolmogorov-Smirnov normality test was
used to evaluate continuous and semi-continuous
data. In order to compare groups, chi-square,
Student’s t (non-paired), Wilcoxon and analysis of the
variance (ANOVA) tests were used. As for the evalua-
tion of the degree of association between groups,
Pearson’s and Spearman’s correlation coefficients
were used. A probability level equal or lower than 5%
(p < 0.05) was considered significant. The sample
number was established non-probabilistically. The
statistical analysis was performed by the Statistical
Package for Social Sciences (SPSS) software, version
13.0 for Windows, SPSS Inc., Chicago, IL).
RESULTS
Translation and pilot study
The committee evaluated two independent ver-
sions translated from English into Brazilian-
Portuguese, resulting in the first Portuguese version
(V1P). This version was submitted to two back-trans-
lations that were unified, resulting in the first English
language version (V1E). After a pilot test including 22
subjects, some modifications in items 3,14,15,16 and
17 were necessary in the second Portuguese version
(V2P). Nevertheless, no significant alteration was
observed when comparing V2P to the original English
version. The V1E and V2P were analyzed and accept-
ed by the authors of the questionnaire, and the Acne-
QoL-Br was created (see flowchart on Figure 2).
Study population
We recruited 114 subjects, but 34 did not fulfill
the inclusion and exclusion criteria (Figure 1). The
study population comprised 80 subjects (52.5%
female, 47.5% male; mean age 20.5 ± 4.8 years; mean
acne duration 6.6 ± 4.4 years) who presented facial
acne, as shown in table 1.
Exclusion criteria
•01 Systemic lupus erithematosus 
•01 Miastenia gravis
•01 Chronical urticaria
•3 Facial melasma
•01 Hyperidrosis
•01 Conglobata acne
•01 Acne only on trunk
•03 Refusal to participate in study
•01 Understanding difficulty
•17 On going acne treatment
•02 No parent permission
•01 No Brazilian citizen 
•01 Missing data
114 assessed
patients 
80 enrolled
patients 
FIGURE 1: Flowchart of the study population (N =80) and the exclu-
sion criteria
FIGURE 2: Flowchart of the translation and cultural adaptation of the
Acne Specific Quality of Life Questionnaire (Acne-QoL) into
Brazilian-Portuguese language
Acne-QoL 
2 Brazilian –Portuguese translations
1st Brazilian – Portuguese version (V1P)
1st English version (V1E)
2 English back-translations 
Final Brazilian – Portuguese version (V2P)
Pilot study
Acne-QoL-Br
Characteristics n %
Age (years)
Mean (SD) 20.5 (4.8)
Range 13 - 35
Gender
Female 42 52.5
Race
Non-Caucasian 51 64.0
Acne duration (years)
Mean (SD) 6.6 (4.4)
Range 0.3 - 21
Acne vulgaris classification (AAD)
Mild 27 33.8
Moderate 29 36.2
Severe 24 30.0
TABLE 1: Clinical and demographic characteristics of the
study population (N=80).
Legend: SD = standard deviation; AAD = American Academy of
Dermatology
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Mean Acne-QoL-Br score was 46.86 ± 22.21, and
mean domain scores were 12.43 ± 7.19 (self-percep-
tion), 12.28 ± 6.93 (role-social), 11.00 ± 6.60 (role-emo-
tional), and 11.16 ± 5.11 (acne symptoms).
Mean SF-36 domain scores were 93.72 ± 12.85
(physical functioning), 89.74 ± 23.64 (role-physical),
77.45 ± 22.00 (bodily pain), 74.15 ±22.97 (general
health), 66.47 ± 16.77 (vitality), 71.63 ± 24.31 (role-
social), 67.95 ±38.53 (role-emotional), and 66.87 ±
18+41 (mental health).
Eighty subject responses to Acne-QoL-Br were ana-
lyzed at baseline and a total of 42 subjects were retested.
Reliability
The internal consistency of the 19 Acne-QoL-Br
items (Cronbach’s α coefficient = 0.925) and of its four
domains were considered satisfactory (Table 2). After
excluding one question, no significant increase in
Cronbach’s α coefficient was observed for each item in
relation to the whole questionnaire (Table 3). The ICC
was considered acceptable in all domains and the
response values were similar for subjects who came
seven days after baseline to retest (Table 2 and 4).
Validity
The correlations between SF-36 role-social and
mental health components and Acne-QoL-Br domains
were considered statistically significant (Table 2).
Acne-QoL-Br components showed strong statistically
significant correlations, both between themselves and
with total Acne-QoL-Br score (Table 5).
Analysis of clinical data
An analysis of acne duration and severity was
performed for all subjects. Mean scores for Acne-QoL-
Br self-perception, role-emotional and acne symptoms
domains were similar in all acne severity groups.
However, a significant difference was observed in the
role-social domain, since patients with mild facial acne
presented higher scores than patients with moderate
acne (p < 0.05). No difference in mean scores was
observed between patients with mild facial acne and
those with severe acne, as well as between patients with
moderate acne and those with severe acne (Table 6).
The subjects who experienced shorter acne
duration presented significant higher role-emotional
and acne symptoms domain scores, as well as margin-
al correlations between role-social and self-perception
domain scores (Table 2).
DISCUSSION
The purpose of this study was to translate and
validate a Brazilian disease-specific instrument for
quality of life assessment in acne patients. The results
of this study corroborate that the Acne-QoL-Br is a
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C N Self- Role- Role- Acne
perception social emotional symptoms
Internal α 80 0.852 0.879 0.764 0.692
consistency
Test-retest ICC 42 0.836 0.782 0.795 0.768
reproducibility
Content validity α 80 0.852 0.879 0.764 0.692
Acne duration r 80 -0.203 -0.200 -0.333* -0.241*
(years)
Convergent validity
SF-36 domains
Physical R 0.186 0.106 -0.017 0.082
functioning
Role-physical R 0.064 0.064 -0.168 -0.207
Bodily pain R 0.107 0.147 0.033 0.042
General health R -0.029 0.053 -0.195 -0.093
Vitality R 0.134 0.208 0.086 0.036
Social R 0.456* 0.386* 0.258* 0.225*
functioning
Role-emotional R 0.174 0.042 -0.065 0.083
Mental health R 0.265* 0.235* 0.183 0.056
TABLE 2: Reliability and validity analysis of the final 19-item
Acne-QoL-Br
Legend: Acne-QoL-Br = Brazilian-Portuguese version of acne-specific
quality of life questionnaire; C = correlation coefficient; α = Cronbach’s
coefficient; ICC = intraclass correlation coefficient; r = Pearson’s correla-
tion coefficient; R = Spearman’s correlation coefficient.
* p < 0.05
Item α
1 0.923
2 0.917
3 0.920
4 0.921
5 0.927
6 0.919
7 0.920
8 0.921
9 0.924
10 0.918
11 0.920
12 0.918
13 0.918
14 0.921
15 0.925
16 0.922
17 0.926
18 0.922
19 0.925
TABLE 3: Redundancy analysis after the exclusion of one
item from the Acne-QoL-Br
Legend: Acne-QoL-Br = Brazilian-Portuguese version of acne-
specific quality of life questionnaire; α = Cronbach’s coefficient
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reliable and valid instrument to assess HRQoL in
facial acne studies.
We followed the translation guidance, cultural
adaptation techniques, and psychometric analysis
methods suggested by the authors who designed the
Acne-QoL and conducted subsequent studies.19-21 The
questions 3,14,15,16 and 17 were slightly altered to
reach conceptual and semantic equivalences.
However, there were no significant structural alter-
ations in the items and in the response numerical scale.
The study population was composed by pas-
sive search for subjects with facial acne. This approach
may be the reason why our sample did not show the
usual distribution as reported in cross-sectional stud-
An Bras Dermatol. 2014;89(1):83-90.
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Domain Test Retest p
P25 Median P75 P25 Median P75
Self-perception 7 9 14 7 9 20 0.063
Role-social 6 9 12 6 10 19 0.333
Role-emotional 7 9 15 6 13 16 0.362
Acne symptoms 7 11 15 11 14 19 0.069
TABLE 4: Comparison of Acne-QoL-Br domain scores bet-
ween test and retest after seven days without any treatment
Legend: Acne-QoL-Br = Brazilian-Portuguese version of acne-
specific quality of life questionnaire; P = percentile
p < 0.05
Domain Self- Role- Role- Acne
perception social emotional symptoms
Self-perception 1.000
Role-social 0.714* 1.000
Role-emotional 0.611* 0.526* 1.000
Acne symptoms 0.575* 0.573* 0.561* 1.000
Total score 0.877* 0.858* 0.775* 0.794*
TABLE 5: Correlations among Acne-QoL-Br domain scores
Legend: Spearman coefficient; * p <0.05
Legend: Acne-QoL-Br = Brazilian-Portuguese version of acne-spe-
cific quality of life questionnaire; AAD = American Academy of
Dermatology
*p < 0.05
Domain Mild Moderate Severe p
N Mean SD N Mean SD N Mean SD
Self- 80 15 8 80 11 7 80 11 6 0.168
perception
Role-social 80 15 7 80 10 8 80 12 6 0.040*
Role- 80 11 7 80 11 5 80 11 7 0.908
emotional
Acne 80 12 5 80 11 6 80 11 5 0.584
symptoms
TABLE 6: Descriptive analysis between Acne-QoL-Br domain
scores and acne severity according to AAD classification
ies concerning severity, age and sex prevalence.32,33
In this study, the Cronbach’s α coefficient val-
ues reflected an adequate level of internal consistency
of the 19 Acne-QoL-Br items,  in accordance with
Fehnel  et al.21 The social domain demonstrated the
highest equivalence, and the acne symptoms domain
score was lower than that of other domains. Although
the coefficient was within the expected ranges, the
smallest capacity of homogeneity noticed in the acne
symptoms domain also occurred in studies that ana-
lyzed the measurement properties of the original
instrument.21,23,25 No redundancy was observed in the
Acne-QoL-Br, since there was no significant alteration
in Cronbach’s α coefficients in the absence of one item.
Thus, in order to obtain a more trustworthy
interpretation of instrument stability, Acne-QoL-Br
reproducibility was evaluated by the similarity of sub-
ject responses at baseline and retest, as described in a
previous study.20 ICC values presented an acceptable
and satisfactory variation, which means that the Acne-
QoL-Br was considered reproducible. The ICC for the
acne symptoms domain showed the lowest value,
probably because the items of this domain refer to
some aspects which allow a slight variation in sub-
ject’s perception of facial acne lesions and seque-
lae.21,24,25 This perception may be heightened or less-
ened. The dynamic and polymorphic behavior of
facial acne and the motivation generated from know-
ing that the treatment would be prescribed after the
second interview are factors that need to be taken into
account. Such findings indicated that items related to
facial acne were stable, since it did not get better or
worse during the period between the two interviews.
Anderson and Rajagopalan  used the ICC to assess
test-retest reliability, with an interval from three to
seven days, obtaining good results.23 Unlike this study,
other validation studies of acne-specific question-
naires used Pearson’s and Spearman’s correlation
coefficients to determine test-retest reliability.22,25 The
ideal interval for retest application of the Acne-QoL-
Br was seven days, ratifying the interval established
by the original instrument and those used in other
studies, i.e., equal or smaller than seven days.19-21,23 A
previous study that used a more comprehensive and
complete methodology (including ICC, Pearson’s
coefficient,  and Student’s test)  was carried out by a
French group, but nevertheless included a small
group of sixteen subjects. The authors decided to use
the Cardiff Acne Disability Index (CADI), which may
not be considered gold standard for clinical trials.34
During the validation phase of this study, a lack
of correlation between facial acne severity and quality
of life was observed, confirming the results from
Martin  et al, except for the Acne-QoL-Br role-social
domain, in which subjects with mild facial acne pre-
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sented higher scores and therefore better quality of life
than those with moderate facial acne.20 The association
between HRQoL questionnaire scores and acne sever-
ity is still controversial, according to studies involving
specific instruments, which observed that HRQoL
evaluation was more consistently correlated with the
severity perceived by the subject than with that
described by the investigator.20 Some studies have
documented a significant correlation,  while others
have reported none or weak correlations.18,22,23,25,35 Our
findings support the hypothesis that, even for subjects
with mild acne, the disease may undermine their self-
confidence, limit public appearances, and impair fam-
ily and work relationships.36
In accordance with some studies, the results of
Acne-QoL-Br validity demonstrated a negative corre-
lation between the scores and how long the subject
has had acne in role-emotional and acne symptoms
domains, and a marginal correlation for other
domains, i.e., subjects with shorter duration experi-
enced better quality of life.29 Layton et al reported that
women, mainly those who have had acne for more
than ten years, presented higher level of compromise
in HRQoL as assessed by APSEA.22 In addition, in a
cohort study with 867 subjects followed up for two
years, Tan et al proved that subjects with the highest
levels of compromise on quality of life evaluated by
the Acne-QoL were those who had had facial acne for
more than five years.37
The correlations of Acne-QoL-Br domain scores
between themselves and with total Acne-QoL-Br score
reinforce the questionnaire unity and keep its multidi-
mensional characteristic as a HRQoL tool. The associ-
ation of role-social and self-perception domains with
total score confirmed the observation of a common
phenomenon among subjects with facial acne, which
is their great concern for their self-image and appear-
ance. By expressing greater concern for self-image
than for work, family or school environment relation-
ships, subjects ratify the intuitive reasoning that facial
acne creates a negative impact and that they feel
embarrassed in their routine activities.5,10 We observed
that the aspects addressed in the self-perception
domain caused negative impact on those related to
public appearance, getting known, and living with
other people, which are inferences drawn in the role-
social domain.35 This corroborates the positive correla-
tion between the two domains, indicating that they
should have contributed significantly for instrument
construction, and validates the hypothesis that they
yielded the expected measures.
The use of a combination of generic and specif-
ic instruments is recommended to reiterate and/or
complement the level of compromise in several
dimensions. Due to the absence of specific question-
naires about acne validated in Brazilian-Portuguese,
the version of a generic questionnaire (the Brazilian-
Portuguese version of the SF-36) was used to verify
Acne-QoL-Br validity. SF-36 measurement properties
were evaluated by different acne studies and different
populations as described by Both et al, reiterating its
sensibility to identify quality of life compromise.38
As facial acne lesions are apparent, a certain
degree of social discomfort may be embedded in this
context. This supports the hypothesis that, even in
subjects with mild acne, the disease may undermine
their self-confidence, limit their public appearances,
and impair their family and work relationships.8 The
correlation between all Acne-QoL-Br domains and the
SF-36 role-social domain, along with the correlations
of Acne-QoL-Br self-perception and social domains
with SF-36 mental health, corroborate the findings
described by a case-control survey.15 A study compris-
ing 111 subjects with facial acne showed that the most
compromised SF-36 domains were role-social and
mental health, while the role-emotional domain pre-
sented some alteration when the patient was followed
up during one year.14 The mental health scores were
worse than those recorded in diseases like asthma,
epilepsy, diabetes, backache and arthritis.14 A case-
control study demonstrated that subjects with facial
acne, according to the United Kingdom Sickness
Impact Profile (UKSIP), felt a greater psychosocial
impact than groups without acne on psychological,
social functioning, and functional capacity domains.35
The statement that acne subjects do not consider
themselves sick was reaffirmed in this study by the
absence of correlation between Acne-QoL-Br and gener-
al health, physical and bodily pain dimensions included
in the SF-36. This demonstrates that general health sta-
tus was preserved, as observed in other studies.14,15
Unlikely, no correlations were perceived either
between Acne-Qol-Br and SF-36 role-emotional
domains and Acne-QoL-Br role-emotional and SF-36
mental health domains in this study. These findings
corroborate the controversies about the association
between psychological alterations and acne, which
has been extensively discussed by several authors.
However, the absence of relevant longitudinal studies
establishing the causal relationship between these
aspects has stirred up the controversy.37
Although Aktan et al analysed 2,657 Turkish stu-
dents, no difference between acne and control groups
was found as far as traces of anxiety and depression
were concerned.32 It should be pointed out that authors
chose the less sensitive scale, the Hospital Anxiety and
Depression Scale (HAD), to assess mental health alter-
ations among teenagers. This scale is rarely used for
patients assisted at psychiatric clinics. In the 1990s,
Gupta  et al, by using the HAD, and Kellet  et al, by
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using the Carroll Rating Scale for Depression (CRSD),
observed that acne subjects had more serious symp-
toms of anxiety and depression than patients with
alopecia areata, atopic dermatitis, psoriasis, and the
normal population.25,39 In the U.K., Smithard et al eval-
uated 317 adolescents with acne aged from 14 to 16
years, standardizing subjects’ age and using a scale
called Strengths and Difficulties Questionnaire (SQD),
which evaluates mental health. Results pointed out a
prevalence of alterations twice more substantial in the
emotional subscale for acne subjects.9
According to the complex and multidimension-
al concept of quality of life, an improvement in psy-
chosocial well-being should be considered a parame-
ter as fundamental as absence of disease.40,41,42
This study proposes that the general physician
or specialist should try to identify which quality of life
dimensions are compromised in facial acne subjects.
Traces of minor mental disorders may also be per-
ceived, thus facilitating the understanding of how
acne affects mental health.
The evaluation of quality of life may be based
on the use of just one question or objective and of
standardized questionnaires. These may sort out
patients either as time passes by or by taking into con-
sideration whether they have other diseases. It is also
possible to predict patient outcomes and evaluate
treatment efficacy.43 HRQoL scales stem from the
necessity to turn “subjective perception into an objec-
tive measurement”, motivated by the discrepancy
between specialist evaluation and patient perception
of disease severity.44,45 However, it is important to men-
tion that by using these instruments one may not gen-
eralize the quality of life perception based only on
scores. As some studies highlight, if a compromise in
role-social is detected by just one instrument, this
information may not necessarily reflect an objective
opinion about subject’s level of quality of life.28,43,45
Acne patients should receive effective and early
treatment as improvement in quality of life after ther-
apy occurs relevantly and substantially, as demonstrat-
ed by various studies using specific instru-
ments.17,37,46,47,48 Disease-specific instruments for der-
matosis acquire a special meaning because they report
in a peculiar way the main perspective related to the
harm inflicted on quality of life, including psychoso-
cial and functional dimensions. Nevertheless, it is
important to highlight that even certain generic instru-
ments, such as SF-36, are able to detect alterations in
quality of life among patients with facial acne.35,49
The physician’s decision concerning therapeu-
tic intervention must be based on clinical parameters,
such as acne severity and extension, and may not be
invalidated by the use of quality of life indicators per
se. It is of key importance to consider subject’s percep-
tion concerning facial acne and the changes in well-
being as complementary criteria.
The lack of correlation between facial acne sever-
ity and Acne-QoL-Br scores observed in this study sug-
gests that patients’ perception of their disease may be
considered in acne evaluation and treatment.
The limitations of this study are: passive search
for subjects with facial acne and lack of analysis of
other measurement properties such as responsiveness
and degree of questionnaire interpretation.
CONCLUSION
In summary, this study was able to establish
that Acne-QoL-Br is a reliable and valid outcome
measure available and applicable in the Brazilian con-
text and a useful instrument to assess HRQoL in sub-
jects with facial acne. These aspects include Brazil in
the scenario of studies of HRQoL related to acne. It is
important that more reports using that questionnaire,
as well as clinical trials, should be carried out in order
to consolidate Acne-QoL-Br validity and to evaluate
its responsiveness and treatment outcomes in patients
with facial acne.q
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